Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · Real-Time Price · USD
59.77
+0.02 (0.03%)
Nov 19, 2024, 3:38 PM EST - Market open
Longboard Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -76.34 | -54.42 | -43.95 | -27.8 | -14.4 |
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0 | - |
| Loss (Gain) From Sale of Investments | -7.73 | -0.97 | 0.1 | 0.16 | - |
| Stock-Based Compensation | 8.79 | 3.25 | 2.66 | 1.97 | 8.51 |
| Change in Accounts Payable | 0.77 | -0.31 | 0.28 | -0.19 | 1.21 |
| Change in Other Net Operating Assets | 8.57 | 1.58 | 2.84 | 1.15 | 1.24 |
| Operating Cash Flow | -65.93 | -50.87 | -38.06 | -24.71 | -3.44 |
| Capital Expenditures | - | - | - | -0.02 | - |
| Investment in Securities | -220.12 | 24.23 | -17.06 | -40.7 | - |
| Investing Cash Flow | -220.12 | 24.23 | -17.06 | -40.72 | - |
| Issuance of Common Stock | 305.11 | 32.28 | - | 84.77 | 3.2 |
| Other Financing Activities | -15.11 | -2.09 | -0.44 | -8.32 | -0.44 |
| Financing Cash Flow | 290 | 30.19 | -0.44 | 76.45 | 58.76 |
| Net Cash Flow | 3.94 | 3.56 | -55.57 | 11.03 | 55.32 |
| Free Cash Flow | -65.93 | -50.87 | -38.06 | -24.72 | -3.44 |
| Free Cash Flow Per Share | -1.92 | -2.24 | -2.22 | -1.72 | -0.90 |
| Levered Free Cash Flow | -36.37 | -30.8 | -22.63 | -15.09 | - |
| Unlevered Free Cash Flow | -36.37 | -30.8 | -22.63 | -15.09 | - |
| Change in Net Working Capital | -9.49 | -1.42 | -2.71 | -0.36 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.